Literature DB >> 18297190

Two pedigrees with restless legs syndrome in Brazil.

A M Esteves1, M Pedrazzoli, M Bagnato, F Moreira, M T de Mello, S Tufik.   

Abstract

Numerous studies have suggested a substantial genetic contribution in the etiology of the primary form of restless legs syndrome (RLS) and periodic leg movements (PLM). We describe the symptoms, the sleep profiles and physiological parameters of two families in which several members present RLS/PLM. The proband of family 1 is a 70-year-old woman and the proband of family 2 is a 57-year-old woman; both have exhibited the symptoms since the age of 20 years. All patients in both families were diagnosed with RLS according to the criteria of the International RLS Study Group. Polysomnographic recordings were performed to quantify and to describe PLM during sleep. Sleep parameters showed decreased sleep efficiency, increased sleep latency in the arousal index and the presence of PLM in all subjects. One of the families showed an exact profile of dominant inheritance with anticipation of age at onset. In the other family, the founders were blood relatives and there was no affected member in the third generation suggesting a recessive mode of inheritance. RLS/PLM is a prevalent sleep disorder affecting about 5 to 15% of the population and one that substantially impairs healthy sleep patterns. Efforts to understand the underlying pathophysiology will contribute to improve the sleep and life quality of these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297190     DOI: 10.1590/s0100-879x2008000200005

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  1 in total

1.  Clinical and polysomnographic features of a large Turkish pedigree with restless leg syndrome and periodic limb movements.

Authors:  Gülsen Babacan-Yildiz; Esra Gürsoy; Mehmet Kolukisa; Fatmanur Karaköse; Emin M Akkoyunlu; Arif Celebi; Ebba Lohmann
Journal:  Sleep Breath       Date:  2012-08-02       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.